{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:22:19Z","timestamp":1791868939436,"version":"4.3.4"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.2215\/cjn.07370715","type":"journal-article","created":{"date-parts":[[2015,12,14]],"date-time":"2015-12-14T23:23:57Z","timestamp":1450135437000},"page":"245-253","source":"Crossref","is-referenced-by-count":135,"title":["Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid\u2013Resistant Nephrotic Syndrome"],"prefix":"10.2215","volume":"11","author":[{"given":"Anja K.","family":"B\u00fcscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo B.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Melk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hoefele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Kranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bamborschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e4rbel","family":"Lange-Sperandio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Jungraithmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz T.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"T\u00f6nshoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20230601","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00467-012-2304-8","article-title":"Treatment of steroid-resistant nephrotic syndrome in children: New guidelines from KDIGO.","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R2-8-20230601","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.ki.5002553","article-title":"Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: Workshop recommendations.","volume":"72","author":"Cattran","year":"2007","journal-title":"Kidney Int"},{"key":"R3-8-20230601","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1046\/j.1523-1755.1999.00778.x","article-title":"A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis.","volume":"56","author":"Cattran","year":"1999","journal-title":"Kidney Int"},{"key":"R5-8-20230601","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archpedi.1988.02150090083029","article-title":"Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study.","volume":"142","author":"Garin","year":"1988","journal-title":"Am J Dis Child"},{"key":"R6-8-20230601","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0272-6386(12)80654-8","article-title":"Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome.","volume":"18","author":"Melocoton","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"R7-8-20230601","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0022-3476(05)82020-7","article-title":"Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone.","volume":"125","author":"Niaudet","year":"1994","journal-title":"J Pediatr"},{"key":"R8-8-20230601","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/ajkd.1998.v31.pm9631836","article-title":"Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.","volume":"31","author":"Hino","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R9-8-20230601","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s004670050536","article-title":"Quantitative morphometry of renal biopsies prior to cyclosporine in nephrotic syndrome.","volume":"12","author":"Smoyer","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"R10-8-20230601","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00467-012-2393-4","article-title":"Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.","volume":"28","author":"Hamasaki","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R11-8-20230601","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1523-1755.2004.00776.x","article-title":"NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.","volume":"66","author":"Weber","year":"2004","journal-title":"Kidney Int"},{"key":"R12-8-20230601","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.ASN.0000113552.59155.72","article-title":"Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.","volume":"15","author":"Ruf","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R13-8-20230601","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2215\/CJN.07200712","article-title":"Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome.","volume":"8","author":"McCarthy","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R14-8-20230601","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00467-009-1372-x","article-title":"Analysis of recessive CD2AP and ACTN4 mutations in steroid-resistant nephrotic syndrome.","volume":"25","author":"Benoit","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R15-8-20230601","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00431-011-1668-2","article-title":"Educational paper: The podocytopathies.","volume":"171","author":"B\u00fcscher","year":"2012","journal-title":"Eur J Pediatr"},{"key":"R16-8-20230601","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2215\/CJN.01190210","article-title":"Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.","volume":"5","author":"B\u00fcscher","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-8-20230601","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5414\/CN107320","article-title":"Mutations in podocyte genes are a rare cause of primary FSGS associated with ESRD in adult patients.","volume":"78","author":"B\u00fcscher","year":"2012","journal-title":"Clin Nephrol"},{"key":"R18-8-20230601","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2215\/CJN.05260610","article-title":"Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.","volume":"6","author":"Sant\u00edn","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R19-8-20230601","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1681\/ASN.2008010059","article-title":"Nephrin mutations can cause childhood-onset steroid-resistant nephrotic syndrome.","volume":"19","author":"Philippe","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R20-8-20230601","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1681\/ASN.2013111155","article-title":"Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression.","volume":"26","author":"Giglio","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R21-8-20230601","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.clinthera.2004.09.012","article-title":"Cyclosporine in patients with steroid-resistant nephrotic syndrome: An open-label, nonrandomized, retrospective study.","volume":"26","author":"Ghiggeri","year":"2004","journal-title":"Clin Ther"},{"key":"R22-8-20230601","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ejhg.2014.252","article-title":"Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: Mutations in multiple glomerular genes may influence disease severity.","volume":"23","author":"Bullich","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"R23-8-20230601","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2215\/CJN.09010813","article-title":"Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome.","volume":"9","author":"Lovric","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R25-8-20230601","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2215\/CJN.06260614","article-title":"Spectrum of steroid-resistant and congenital nephrotic syndrome in children: The PodoNet registry cohort.","volume":"10","author":"Trautmann","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R26-8-20230601","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00467-015-3109-3","article-title":"Response to cyclosporine in steroid-resistant nephrotic syndrome: Discontinuation is possible.","volume":"30","author":"Klaassen","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"R27-8-20230601","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01956754","article-title":"Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie.","volume":"152","author":"Ehrich","year":"1993","journal-title":"Eur J Pediatr"},{"key":"R29-8-20230601","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","article-title":"A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.","volume":"26","author":"Sadowski","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R30-8-20230601","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1681\/ASN.2009121309","article-title":"Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome.","volume":"21","author":"Machuca","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R31-8-20230601","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00467-005-2097-0","article-title":"Differential risk of remission and ESRD in childhood FSGS.","volume":"21","author":"Gipson","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R32-8-20230601","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.2004070593","article-title":"Focal and segmental glomerulosclerosis: Definition and relevance of a partial remission.","volume":"16","author":"Troyanov","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R33-8-20230601","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ndt\/gfh766","article-title":"Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.","volume":"20","author":"Mahmoud","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R34-8-20230601","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00467-010-1468-3","article-title":"Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations.","volume":"25","author":"Gellermann","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R35-8-20230601","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00467-009-1211-0","article-title":"Partial remission with cyclosporine A in a patient with nephrotic syndrome due to NPHS2 mutation.","volume":"24","author":"Malina","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R36-8-20230601","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med"},{"key":"R37-8-20230601","doi-asserted-by":"crossref","first-page":"e55980","DOI":"10.1371\/journal.pone.0055980","article-title":"Protective effects of the mTOR inhibitor everolimus on cytoskeletal injury in human podocytes are mediated by RhoA signaling.","volume":"8","author":"Jeruschke","year":"2013","journal-title":"PLoS One"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201602000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:46:00Z","timestamp":1786369560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201602000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.07370715","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}